| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 65.756 | 40.792 | 30.588 | 39.227 | 34.639 | 47.104 | 44.990 | 46.215 | 46.687 | 58.353 |
| Total Income - EUR | 65.756 | 40.823 | 30.667 | 39.368 | 34.756 | 47.258 | 45.065 | 46.511 | 46.821 | 59.063 |
| Total Expenses - EUR | 64.379 | 41.088 | 34.782 | 44.041 | 36.959 | 43.166 | 44.583 | 46.672 | 49.697 | 62.423 |
| Gross Profit/Loss - EUR | 1.378 | -264 | -4.115 | -4.673 | -2.203 | 4.093 | 482 | -161 | -2.877 | -3.360 |
| Net Profit/Loss - EUR | 1.378 | -673 | -4.422 | -5.067 | -2.550 | 3.794 | 119 | -627 | -3.345 | -3.951 |
| Employees | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Genes Impex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 342 | 345 | 0 | 0 | 0 | 0 | 492 | 290 | 85 | 0 |
| Current Assets | 14.643 | 14.658 | 15.984 | 18.544 | 17.044 | 8.161 | 6.360 | 6.931 | 7.387 | 7.211 |
| Inventories | 13.314 | 14.274 | 15.511 | 18.272 | 16.740 | 5.882 | 4.914 | 5.390 | 5.906 | 4.127 |
| Receivables | 364 | 218 | 174 | 71 | 6 | 1.430 | 1.311 | 1.315 | 1.366 | 2.879 |
| Cash | 965 | 166 | 299 | 201 | 298 | 848 | 135 | 225 | 115 | 205 |
| Shareholders Funds | -51.292 | -51.442 | -54.993 | -59.051 | -60.458 | -55.518 | -54.167 | -54.962 | -58.140 | -61.766 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 66.277 | 66.445 | 70.977 | 77.595 | 77.502 | 63.678 | 61.020 | 62.196 | 65.612 | 68.977 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Genes Impex S.r.l.